Citalopram for agitation in Alzheimer’s disease (CitAD): design and methods

BACKGROUND: Agitation is one of the most common neuropsychiatric symptoms of Alzheimer’s disease (AD), and is associated with serious adverse consequences for patients and caregivers. Evidence-supported treatment options for agitation are limited. The citalopram for agitation in Alzheimer’s disease...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Drye, Lea T., Ismail, Zahinoor, Porsteinsson, Anton P., Rosenberg, Paul B., Weintraub, Daniel, Marano, Christopher, Pelton, Gregory, Frangakis, Constantine, Rabins, Peter V., Munro, Cynthia A., Meinert, Curtis L., Devanand, D.P., Yesavage, Jerome, Mintzer, Jacobo E., Schneider, Lon S., Pollock, Bruce G., Lyketsos, Constantine G.
Формат: Artigo
Язык:Inglês
Опубликовано: 2012
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3333484/
https://ncbi.nlm.nih.gov/pubmed/22301195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2011.01.007
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы